Thomas McCauley - 09 Mar 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Chief Scientific Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Thomas McCauley, Ph.D
Issuer symbol
OMGAQ
Transactions as of
09 Mar 2022
Net transactions value
$0
Form type
4
Filing time
11 Mar 2022, 15:05:29 UTC
Previous filing
29 Jul 2021
Next filing
28 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +110,000 $0.000000 110,000 09 Mar 2022 Common Stock 110,000 $10.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on March 9, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 9, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.